V020-6573 Screening compound: 11-{4-[(4-fluorophenyl)sulfonyl]-3-methylpiperazino}-2,7-dimethyldibenzo[b,f][1,4]oxazepine

V020-6573 Screening compound: 11-{4-[(4-fluorophenyl)sulfonyl]-3-methylpiperazino}-2,7-dimethyldibenzo[b,f][1,4]oxazepine
V020-6573 Screening compound: 11-{4-[(4-fluorophenyl)sulfonyl]-3-methylpiperazino}-2,7-dimethyldibenzo[b,f][1,4]oxazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-6573
11-{4-[(4-fluorophenyl)sulfonyl]-3-methylpiperazino}-2,7-dimethyldibenzo[b,f][1,4]oxazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-6573

Molecular Formula

C26H26FN3O3S (C26 H26 FN3 O3 S)

Compound Name

11-{4-[(4-fluorophenyl)sulfonyl]-3-methylpiperazino}-2,7-dimethyldibenzo[b,f][1,4]oxazepine

IUPAC name

10-[4-(4-fluorobenzenesulfonyl)-3-methylpiperazin-1-yl]-513-dimethyl-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)35791214-heptaene

SMILES

CC(CN(CC1)C2=Nc(ccc(C)c3)c3Oc3c2cc(C)cc3)N1S(c(cc1)ccc1F)(=O)=O

InChI

InChI=1S/C26H26FN3O3S/c1-17-5-11-24-22(14-17)26(28-23-10-4-18(2)15-25(23)33-24)29-12-13-30(19(3)16-29)34(31,32)21-8-6-20(27)7-9-21/h4-11,14-15,19H,12-13,16H2,1-3H3/t19-/m0/s1

InChI Key

OTBRPOIZIPNKIG-IBGZPJMESA-N

MDL Number (MFCD)

MFCD14284421

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.148

Distribution Coefficient, logD

4.033

Water Solubility, LogSw

-5.08

Polar Surface Area

49.776

Acid Dissociation Constant (pKa)

25.89

Base Dissociation Constant (pKb)

8.48

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.90

V020-6573 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-6573 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-6573?
Check Price and Availability of V020-6573, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-6573 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-6573
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-6573
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-6573 available by request